These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8130017)

  • 21. Impact of therapy on left ventricular remodeling after myocardial infarction: an echocardiographic perspective.
    Popović AD
    Cardiologia; 1997 Jul; 42(7):681-6. PubMed ID: 9270178
    [No Abstract]   [Full Text] [Related]  

  • 22. Potentiation of fibrinolytic therapy in acute myocardial infarction: expanding the role of ACE-inhibitors.
    Andreotti F; Biondi-Zoccai GG
    Thromb Haemost; 2002 Aug; 88(2):176-8. PubMed ID: 12195684
    [No Abstract]   [Full Text] [Related]  

  • 23. Myocardial infarction: ACE inhibitors for all? For ever?
    Simoons ML
    Lancet; 1994 Jul; 344(8918):279-81. PubMed ID: 7980780
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical benefit of angiotensin converting enzyme inhibition after acute myocardial infarction: myocardial reperfusion revisited.
    Renkin J
    J Hypertens Suppl; 1996 Dec; 14(6):S15-9. PubMed ID: 9023710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.
    Pfeffer MA
    Herz; 1993 Dec; 18 Suppl 1():430-5. PubMed ID: 8125423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pragmatic approach to the use of angiotensin-converting enzyme inhibitors in acute myocardial infarction.
    Vantrimpont P; Rouleau JL
    Can J Cardiol; 1996 Oct; 12(10):924-9. PubMed ID: 9191482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction.
    Jugdutt BI; Lucas A; Khan MI
    Can J Cardiol; 1997 Jul; 13(7):657-68. PubMed ID: 9251578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Angiotensin-converting enzyme inhibitors following a myocardial infarct: clinical abd echographic indications].
    de Waard DE; Kamp O; Visser FC; Visser CA
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):84-8. PubMed ID: 9036352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.
    Plosker GL; McTavish D
    Drugs Aging; 1995 Sep; 7(3):226-53. PubMed ID: 8535052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE inhibitors after myocardial infarction.
    Kleist P
    Lancet; 1994 Jun; 343(8913):1633; author reply 1633-4. PubMed ID: 7911934
    [No Abstract]   [Full Text] [Related]  

  • 32. ACE inhibitors after myocardial infarction.
    Hall AS; Cooke GA; Tan LB
    Lancet; 1994 Jun; 343(8913):1632-3; author reply 1633-4. PubMed ID: 7911933
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of ACE inhibitors after myocardial infarction.
    Rutherford JD
    Coron Artery Dis; 1995 Apr; 6(4):281-7. PubMed ID: 7655710
    [No Abstract]   [Full Text] [Related]  

  • 34. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibition in myocardial infarction--Part 1: Clinical data.
    Huckell VF; Bernstein V; Cairns JA; Crowell R; Dagenais GR; Higginson LA; Isserow S; Laramée P; Liu P; McCans JL; Orchard RC; Prewitt R; Quinn BP; Samson M; Turazza F; Warnica JW; Wielgosz A
    Can J Cardiol; 1997 Feb; 13(2):161-9. PubMed ID: 9070168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
    Pitt B
    Cardiology; 1995; 86 Suppl 1():41-5. PubMed ID: 7614506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The SAVE trial: rational basis, results, and reflections].
    Gomes MC; Maciel MJ
    Rev Port Cardiol; 1992 Sep; 11(9):709-21. PubMed ID: 1476763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological intervention in post-infarction wound healing.
    Jugdutt BI
    EXS; 1996; 76():501-12. PubMed ID: 8805815
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardioprotection and ACE inhibitors.
    Ball SG
    Clin Physiol Biochem; 1992; 9(3):98-104. PubMed ID: 1302164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Angiotensin converting enzyme inhibitors in arterial hypertension].
    Ramón González-Juanatey J
    Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.